Market Expansion Potential DermTech's focus on precision dermatology and non-invasive skin genomics presents significant opportunities to expand into dermatology clinics, hospitals, and specialized skin centers seeking innovative melanoma assessment solutions.

Strategic Partnership Opportunities Collaborations with pharmaceutical companies, research institutions, or healthcare providers involved in melanoma research and skin cancer diagnostics could accelerate product adoption and broaden DermTech's market reach.

Product Differentiation DermTech's unique Smart Sticker technology and non-invasive testing methods position it favorably against traditional biopsy-based diagnostics, creating opportunities to upsell to clinics and labs aiming for cutting-edge, patient-friendly solutions.

Financial Recovery Strategies Given the recent financial challenges and bankruptcy filing, offering tailored financial solutions, leasing options, or investment collaborations could help stabilize operations and attract customers interested in cost-effective, innovative diagnostics.

Targeted Customer Segments Focusing on specialized segments such as dermatology practices, skin cancer screening programs, and research organizations can maximize dermTech's current capabilities and generate new sales channels for its genomics-based melanoma assessment tools.